For retatrutide, Eli Lillys core patents covering the compound appear to have been filed in 2018
However, the GLP-1 saga turns out, the fact that these drugs have popped up seemingly out of nowhere, and have generated such excitement, highlights the potential existing in the huge repurposed drug (drugs used in another condition than for which they are approved) market for these diseases
With demand remaining strong across pharmacies, clinics, and healthcare providers, buyers should continue watching pricing trends and availability throughout the year.
Iron contributes to DNA synthesis, metabolism, and enzymatic activity in oxygen reactions, and its acquisition is of paramount importance for development, cell growth, and survival